Authors: HANDE K WILDING G RIPPLE G FRY J ARZOOMANIAN R DIXON M YUEN G COLLIER M

Citation: K. Hande et al., A PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE (MMP) INHIBITOR, IN PATIENTS HAVING ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 279-279

Authors: WILDING G SMALL E RIPPLE G KELLER M YUEN G COLLIER M

Citation: G. Wilding et al., PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE INHIBITOR, IN COMBINATION WITH MITOXANTRONE PREDNISONE IN PATIENTS HAVING ADVANCED PROSTATE-CANCER/, Annals of oncology, 9, 1998, pp. 280-280

Authors: BAILEY H RIPPLE G GOULD M ARZOOMANIAN R ALBERTI D FEIERABEND C SIMON K MORGAN K TUTSCH K POMPLUN M WAHAMAKI A MARNOCHA R WILDING G

Citation: H. Bailey et al., PHASE-I TRIALS OF PERILLYL ALCOHOL ADMINISTERED ORALLY ON A CONTINUOUS DAILY BASIS, Annals of oncology, 9, 1998, pp. 409-409

Authors: BAILEY HH RIPPLE G TUTSCH KD ARZOOMANIAN RZ ALBERTI D FEIERABEND C MAHVI D SCHINK J POMPLUN M MULCAHY RT WILDING G

Citation: Hh. Bailey et al., PHASE-I STUDY OF CONTINUOUS-INFUSION L-S,R-BUTHIONINE SULFOXIMINE WITH INTRAVENOUS MELPHALAN, Journal of the National Cancer Institute, 89(23), 1997, pp. 1789-1796